Pulike Biological Engineering, Inc.

Shanghai Stock Exchange 603566.SS

Pulike Biological Engineering, Inc. Inventory for the year ending December 31, 2023: USD 25.86 M

Pulike Biological Engineering, Inc. Inventory is USD 25.86 M for the year ending December 31, 2023, a -5.90% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Pulike Biological Engineering, Inc. Inventory for the year ending December 31, 2022 was USD 27.48 M, a 2.39% change year over year.
Pulike Biological Engineering, Inc. Inventory for the year ending December 31, 2021 was USD 26.84 M, a 30.94% change year over year.
Pulike Biological Engineering, Inc. Inventory for the year ending December 31, 2020 was USD 20.50 M, a 20.93% change year over year.
Pulike Biological Engineering, Inc. Inventory for the year ending December 31, 2019 was USD 16.95 M, a 20.73% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

Shanghai Stock Exchange: 603566.SS

Pulike Biological Engineering, Inc.

CEO	Mr. Wei Hu
IPO Date	May 18, 2015
Location	China
Headquarters	No.15 Zhenghe Road
Employees	1,679
Sector	Healthcare
Industries Biotechnology Pet Food Pharmaceuticals Vaccines

Description

Pulike Biological Engineering, Inc. engages in the research and development, production, and marketing of veterinary biological products and drugs. It offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. The company is headquartered in Luoyang, China.

Key trends

Past 5 years